[Turn 3: Agent V3]
field: Computational chemistry and analytical methods (DFT calculations, conformational analysis, quantitative data quality)
field_rationale: The paper reports ground-state DFT conformational energy calculations as primary evidence for the N-substitution design rationale — the central justification for why PMB rather than unprotected or N-Ph substrates were pursued — which triggers the computational chemistry perspective. Additionally, V1 and V2 have not examined data quality issues with the primary analytical measurements (SFC-MS ee, ¹H NMR yield) or the reliability and scope of the conformational calculations that underpin substrate design decisions.

--- New questions ---

V3-Q1
loc: P2:Lcol:L28-38*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: What level of DFT theory and basis set were used for these conformational calculations, and were solvent effects (implicit or explicit) included? A 5.7 kcal/mol gas-phase conformational energy difference could be substantially altered in a polar solvent (BuCN, ε ≈ 20), and without specifying the computational method and conditions it is impossible to assess whether the calculated values reliably predict solution-phase behavior.
severity: medium
inference_tier: T1

V3-Q2
loc: P2:Lcol:L28-38*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Do the ground-state s-cis/s-trans energy differences correlate with the observed experimental reactivity trend across all N-substituents tested? The paper reports calculated ΔE values only for R = H and R = Me, but N-PMB, N-Ph, N-Et, N-Cy, and N-CH₂CH₂Ph substrates all show different reactivity. Were analogous calculations performed for these substituents, and do they predict the reactivity ordering (N-PMB ≈ N-Me > N-Et ≈ N-Cy > N-Ph ≈ N-H)?
severity: medium
inference_tier: T2 [paper-grounded inference]

V3-Q3
loc: P3:Rcol:L18-28*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: What is the actual ΔE between s-cis and s-trans for the N-Ph substrate, and at what level of theory was it calculated? The paper states s-cis is "energetically accessible" for N-Ph but provides no numerical value; without this, the claim that conformation is not the cause of N-Ph inhibition rests on a qualitative assertion rather than a quantitative comparison.
severity: medium
inference_tier: T1

V3-Q4
loc: P2:Rcol:L30-36* (Table 1 footnote)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: What is the measurement uncertainty (standard deviation) of the ¹H NMR yield and SFC-MS ee determinations? The optimization table reports yields to the nearest percent and ee values with apparent precision of ±1%, but whether reactions were performed in duplicate or triplicate—and the actual analytical precision—is not stated. Specifically, entries 4 and 5 differ in yield by 9% (85% vs. 94%); is this difference statistically significant or within measurement noise?
severity: medium
inference_tier: T1

V3-Q5
loc: P2:Rcol:L10-14* (footnote 20 region)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: How was ee accuracy validated for each substrate in Scheme 3? Reference 20 describes a general SFC-MS method for ee determination, but chiral SFC resolution quality is substrate-dependent. Were racemic standards (e.g., from reactions without chiral ligand) prepared to validate baseline resolution for each of the 21 substrates in the scope table?
severity: medium
inference_tier: T2 [paper-grounded inference]

V3-Q6
loc: P2:Lcol:L1-8* (Scheme 3 footnote region)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: What were the exact yield and ee values at gram scale for product 5? "Similar" is not quantified; reproducibility at gram scale is a critical metric for pharmaceutical applications (which the paper emphasizes with the mephenytoin synthesis), and a quantified deviation from the 0.5 mmol result would be needed for meaningful comparison.
severity: medium
inference_tier: T1

V3-Q7
loc: P5:Lcol:L24-28*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: What are the measured and literature specific optical rotation ([α]D) values for (R)-mephenytoin 30, and at what concentration, solvent, and wavelength were they determined? "Matching" without a numerical comparison does not allow independent verification of the absolute configuration assignment, particularly because optical rotations of scalemic samples depend sensitively on ee.
severity: high
inference_tier: T1

V3-Q8
loc: P2:Rcol:L2-8* (Scheme 2 caption)
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: What statistical criterion was used to define "uniquely effective," and were HTE reactions run in single or multiple replicates per ligand? In HTE campaigns, single-replicate screening conflates assay noise with true ligand effects; a defined statistical cutoff (e.g., >2σ above mean ee) rather than visual selection is required to justify the claim that L1 is uniquely effective.
severity: medium
inference_tier: T2 [paper-grounded inference]

--- Overlaps with V1/V2 ---

V3-OV1
overlaps_with: V1-Q8
severity_V3: medium
note: From an analytical chemistry perspective, the absence of a clear statement about which products in Scheme 3 received full spectral characterization vs. NMR yield only is a data documentation gap that affects reproducibility and peer verification.

V3-OV2
overlaps_with: V1-Q14
severity_V3: high
note: Assigning absolute configuration by analogy (assuming all products from L1 give the same facial selectivity as compound 25) is an inferential claim, not a measurement; analytical chemistry requires direct stereochemical verification (e.g., X-ray crystal structure of at least one representative spirocyclic or non-PMB-bearing product) for a comprehensive scope paper.

V3-OV3
overlaps_with: V2-Q4
severity_V3: medium
note: From a data-analysis perspective, confounding temperature and solvent changes in the optimization table means that ΔΔG‡ cannot be extracted from the reported data, and even a single-temperature isosolvent series was not provided.

V3-OV4
overlaps_with: V1-Q10
severity_V3: medium
note: The ee retention during hydrogenation of 29 to give 30 is not directly verified analytically; direct ee measurement of final product 30 (rather than indirect optical rotation matching) would constitute rigorous confirmation.

V3-OV5
overlaps_with: V1-Q4
severity_V3: medium
note: The claim that the diastereomeric ligand gave "much lower" yield and ee is presented without quantitative values or statistical context, which precludes rigorous assessment of the indane stereocenter's contribution to enantioinduction.

---

> **Tier 8 redaction notice**: This file is a redacted copy of the corresponding Tier 3 / Tier 9 output. Verbatim source-paper quotations have been replaced by `[REDACTED: see source paper §<loc>; full text retained in Tier 9 reviewer-only deposit]` markers, preserving location references and our own analytical content. Bibliographic fields (title, authors, journal, year, DOI), analytical labels (`evidence_chain:` with B-/U-/A-/C- internal IDs), short technical terms, and our own analytical text are not redacted. The redaction was applied by `scripts/redact_for_tier8.py` and, for this version, by `scripts/build_paperA_R1_public.py` with `scripts/redact_source_ngram_runs.py` (scripts of the project repository; they are not deposited).
